CSI Market
Sign In | Register

Takeda Pharmaceutical Limited (TAK) Annual Balance Sheets

Annual · GAAP · USD millions
Access TAK quarterly Balance Sheets →
From Takeda Pharmaceutical Limited through Mar 31 2021, shifts in Mar 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 31 2025)
(Mar 31 2024) (Mar 31 2023) (Mar 31 2022) (Mar 31 2021)
Assets
Cash And Cash Equivalents2,569.13
Current Tax Assets Current100.57
Cash & Short-term Investments2,669.00
Accounts receivable5,142.73
Trade & Other Current Receivables (IFRS combined total)4,732.92
Notes Receivable, Current105.33
Inventories8,121.07
Other Current Assets13,058.29
Total Current Assets16,819.15
Equipment/Property/Plant Net0.00
Goodwill net35,519.86
Intangible Assets24,226.54
Deferred Tax Assets2,473.28
Other Assets, Noncurrent38,422.93
Trade And Other Current Receivables4,519.20
Current Financial Assets130.43
Other Current Assets1,016.65
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners85.34
Noncurrent Assets74,700.47
Investment Accounted For Using Equity Method68.81
Noncurrent Financial Assets2,236.62
Total Assets95,052.27
Liabilities
Accounts Payable3,172.39
Longterm Borrowings26,459.80
Current Provisions3,556.64
Total Current Liabilities16,721.28
Long-term debt525.78
Total Long-term Debt525.78
Deferred Tax Liabilities, Net LI234.51
Noncurrent Provisions17,168.11
Other Current Liabilities3,798.25
Other Noncurrent Financial Liabilities3,509.16
Noncurrent Recognised Liabilities Defined Benefit Plan862.67
Current Borrowings And Current Portion Of Noncurrent Borrowings3,496.67
Trade And Other Current Payables3,029.14
Other Current Financial Liabilities1,395.77
Current Tax Liabilities Current850.36
Total Liabilities48,781.59
Stockholders' Equity
Other Equity44,179.94
Common Stockholder's Equity44,179.94
Total Stockholder's Equity46,270.68
Liabilities & Stockholder's Equity95,052.27
4 historic quarters locked

Sign in to unlock the full Takeda Pharmaceutical Limited balance sheet history.

Sign In Create Free Account

About Takeda Pharmaceutical Co Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20260331)
  • Filed with the SEC: June 17, 2026
  • Source: tak-20260331.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001395064-26-000177

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License